February 6, 2025
TOPLINE: Pathologic complete response shows poor surrogacy for overall survival (OS) in neoadjuvant breast cancer (BC) trials, while invasive disease-free survival demonstrates moderate to strong association […]
February 6, 2025
Although Canada has a national mandate to make some medical services universally available, its patchwork of provincial approaches to covering cancer treatment leaves many patients facing […]
February 6, 2025
TOPLINE: In women aged ≥ 70 years with luminal A–like early breast cancer who had undergone breast-conserving surgery, radiotherapy is associated with better health-related quality-of-life (QoL) […]
February 5, 2025
TOPLINE: Patients with clinically node-negative breast cancer after neoadjuvant chemotherapy demonstrated low axillary and locoregional recurrence rates after sentinel lymph node biopsy (SLNB) or targeted axillary […]
February 5, 2025
The global Common Sense Oncology initiative, launched in 2023, aims to transform the cancer research and care landscape to put patient interests and outcomes first. The […]
February 5, 2025
The COVID-19 pandemic has disrupted cancer care at every stage, from screenings to follow-ups, with effects still being felt almost 2 years after the World Health […]
February 4, 2025
It is the best possible news after an advanced melanoma diagnosis: A clean 10-year scan. This, in all likelihood, means the patient is cured and can […]
February 4, 2025
TOPLINE: Perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) demonstrates superior outcomes than preoperative chemoradiotherapy in resectable esophageal adenocarcinoma, with overall survival at 3 years […]
February 4, 2025
A successful multifaceted intervention to reduce postpartum hemorrhage (PPH) and maternal mortality (MM) in Sub-Saharan Africa — and the related confirmation of a link between prenatal […]